Karlsen TH - Search Results

1

Primary sclerosing cholangitis in genetically diverse populations listed for liver transplantation: unique clinical and human leukocyte antigen associations.

Bowlus CL, Li CS, Karlsen TH, Lie BA, Selmi C. Bowlus CL, et al. Among authors: karlsen th. Liver Transpl. 2010 Nov;16(11):1324-30. doi: 10.1002/lt.22161. Liver Transpl. 2010. PMID: 21031548 Free PMC article.

2

Analysis of MAdCAM-1 and ICAM-1 polymorphisms in 365 Scandinavian patients with primary sclerosing cholangitis.

Bowlus CL, Karlsen TH, Broomé U, Thorsby E, Vatn M, Schrumpf E, Lie BA, Boberg KM. Bowlus CL, et al. Among authors: karlsen th. J Hepatol. 2006 Nov;45(5):704-10. doi: 10.1016/j.jhep.2006.03.012. Epub 2006 Apr 25. J Hepatol. 2006. PMID: 16750586

3

Polymorphisms in the steroid and xenobiotic receptor gene influence survival in primary sclerosing cholangitis.

Karlsen TH, Lie BA, Frey Frøslie K, Thorsby E, Broomé U, Schrumpf E, Boberg KM. Karlsen TH, et al. Gastroenterology. 2006 Sep;131(3):781-7. doi: 10.1053/j.gastro.2006.05.057. Gastroenterology. 2006. PMID: 16952547

4

Genetic polymorphisms associated with inflammatory bowel disease do not confer risk for primary sclerosing cholangitis.

Karlsen TH, Hampe J, Wiencke K, Schrumpf E, Thorsby E, Lie BA, Broomé U, Schreiber S, Boberg KM. Karlsen TH, et al. Am J Gastroenterol. 2007 Jan;102(1):115-21. doi: 10.1111/j.1572-0241.2006.00928.x. Epub 2006 Nov 13. Am J Gastroenterol. 2007. PMID: 17100974

5

Particular genetic variants of ligands for natural killer cell receptors may contribute to the HLA associated risk of primary sclerosing cholangitis.

Karlsen TH, Boberg KM, Olsson M, Sun JY, Senitzer D, Bergquist A, Schrumpf E, Thorsby E, Lie BA. Karlsen TH, et al. J Hepatol. 2007 May;46(5):899-906. doi: 10.1016/j.jhep.2007.01.032. Epub 2007 Feb 27. J Hepatol. 2007. PMID: 17383044

6

Cholangiocarcinoma in primary sclerosing cholangitis is associated with NKG2D polymorphisms.

Melum E, Karlsen TH, Schrumpf E, Bergquist A, Thorsby E, Boberg KM, Lie BA. Melum E, et al. Among authors: karlsen th. Hepatology. 2008 Jan;47(1):90-6. doi: 10.1002/hep.21964. Hepatology. 2008. PMID: 18023027

7

Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis.

Lorentzen AR, Karlsen TH, Olsson M, Smestad C, Mero IL, Woldseth B, Sun JY, Senitzer D, Celius EG, Thorsby E, Spurkland A, Lie BA, Harbo HF. Lorentzen AR, et al. Among authors: karlsen th. Ann Neurol. 2009 Jun;65(6):658-66. doi: 10.1002/ana.21695. Ann Neurol. 2009. PMID: 19630074

8

Genome-wide association analysis in primary sclerosing cholangitis.

Karlsen TH, Franke A, Melum E, Kaser A, Hov JR, Balschun T, Lie BA, Bergquist A, Schramm C, Weismüller TJ, Gotthardt D, Rust C, Philipp EE, Fritz T, Henckaerts L, Weersma RK, Stokkers P, Ponsioen CY, Wijmenga C, Sterneck M, Nothnagel M, Hampe J, Teufel A, Runz H, Rosenstiel P, Stiehl A, Vermeire S, Beuers U, Manns MP, Schrumpf E, Boberg KM, Schreiber S. Karlsen TH, et al. Gastroenterology. 2010 Mar;138(3):1102-11. doi: 10.1053/j.gastro.2009.11.046. Epub 2009 Nov 26. Gastroenterology. 2010. PMID: 19944697

9

Update on primary sclerosing cholangitis.

Karlsen TH, Schrumpf E, Boberg KM. Karlsen TH, et al. Dig Liver Dis. 2010 Jun;42(6):390-400. doi: 10.1016/j.dld.2010.01.011. Epub 2010 Feb 20. Dig Liver Dis. 2010. PMID: 20172772 Review.

10

Genetic associations in Italian primary sclerosing cholangitis: heterogeneity across Europe defines a critical role for HLA-C.

Hov JR, Lleo A, Selmi C, Woldseth B, Fabris L, Strazzabosco M, Karlsen TH, Invernizzi P. Hov JR, et al. Among authors: karlsen th. J Hepatol. 2010 May;52(5):712-7. doi: 10.1016/j.jhep.2009.11.029. Epub 2010 Mar 4. J Hepatol. 2010. PMID: 20347497

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

245 results

Search Page